Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Excess growth hormone"'
Publikováno v:
AACE Clinical Case Reports, Vol 5, Iss 1, Pp e27-e30 (2019)
Objective: Excess growth hormone (GH) secretion from a cystic sellar lesion is rare. Indeed, there have been few cases of hormone-secreting pituitary adenomas with a cystic component.Methods: We report a rare case of subclinical acromegaly that prese
Autor:
Jonathan A. Young, Edward O. List, Darlene E. Berryman, Erin R. Murphy, John J. Kopchick, Ronan K. Carroll, Jaycie Kuhn, Maria Onusko, Elizabeth A. Jensen, Zachary Jackson
Publikováno v:
Journal of the Endocrine Society
Emerging evidence proposes that the gut microbiome has an vital role in host growth, metabolism and endocrinology. That is, gut microbes impact growth by potentially altering the growth hormone (GH)/insulin-like growth factor-1 axis. Our previous res
Autor:
Hatem Eid
Publikováno v:
Endocrine Abstracts.
Autor:
María Luisa Granada
Publikováno v:
Minerva endocrinologica. 44(2)
Acromegaly is a rare disease caused by excess growth hormone (GH) secretion leading to an insulin-like growth factor-1 (IGF-I) which is the major mediator of GH action. Biochemical diagnosis of GH excess is accomplished by the combined measurement of
Autor:
Stijn J.M. Niessen
Publikováno v:
In Practice. 35:2-6
Feline acromegaly is a clinical syndrome resulting from excess growth hormone production (hypersomatotropism). In most cats, this is caused by a functional benign pituitary tumour. Although the condition was previously thought to be rare, recent stud
Autor:
Gareth J. Padfield, Andrew D. Krahn
Publikováno v:
Circulation. 134(6)
We thank Aparci et al for their interest in our article1 and for the interesting points they raise. We agree that the pathogenesis of ventricular arrhythmias in anorexia nervosa (AN) is likely to be multifactorial; however, the argument that excess g
Publikováno v:
Frontiers in Surgery
Frontiers in Surgery, Vol 3 (2016)
Frontiers in Surgery, Vol 3 (2016)
The current treatment of pituitary adenomas requires a balance of conservative management, surgical resection, and in select tumor types, molecular therapy. Acromegaly treatment is an evolving field where our understanding of molecular targets and dr
Autor:
Soo Kyoung Kim, Kwang-Won Kim, Jae Hyeon Kim, Sunghwan Suh, Kyu Yeon Hur, Jae Hoon Chung, Jong Hyun Kim, Moon-Kyu Lee, Ji In Lee, Yong Ki Min
Publikováno v:
Journal of Korean Medical Science
The aim of this study was to assess the prevalence of diabetes and to study the effects of excess growth hormone (GH) on insulin sensitivity and β-cell function in Korean acromegalic patients. One hundred and eighty-four acromegalic patients were an
Publikováno v:
Ожирение и метаболизм, Vol 7, Iss 4, Pp 44-47 (2010)
Acromegaly is a severe neuroendocrine disease that develops when the pituitary gland produces excess growth hormone (GH). Acromegaly is not only a cosmetic problem. Hypersecretion of GH leads to variety complications, decreased quality of life, short
Autor:
V. Chandramouli, C. Höybye, W. C. Schumann, Suad Efendic, A. Wajngot, A.-L. Hulting, B. R. Landau
Publikováno v:
Hormone and Metabolic Research. 40:498-501
The diabetogenic effect of excess growth hormone (GH) such as that in acromegaly is well known. However, the contribution of the various components to hepatic glucose production (HGP) is not completely understood. In this study we evaluated insulin r